CRL vs GEL · rev $2.00B vs rev $978.5M
Charles River Laboratories (CRL) versus Genesis Energy LP (GEL) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Genesis Energy LP (GEL) is a oil & gas midstream company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported GEL revenue for 2026-06-30 was $978.5M. Net income was $49.7M. GEL currently screens at market cap $1.74B.
CRL currently screens at market cap $7.78B. GEL currently screens at market cap $1.74B.
Not investment advice. Open the CRL and GEL stock pages for the full models.
Not investment advice.